Organometallics
Article
crystals suitable for X-ray analysis were obtained by cooling a
dichloromethane/diethyl ether (1/5) solution of 3. For NMR labeling,
see Figure S12 in the Supporting Information.
H
arom), 6.20 (m, 2H, Harom), 5.70 (s, 5H, Cp), 4.00 (m, 4H, H23, H25),
3.68 (m, 2H, H20), 3.53 (m, 2H, H15, H16), 3.06 (m, 4H, H17, H18),
2.83 (m, 2H, H19), 2.73 (s, 6H, H21, H22), 1.52 (t, 3JH−H = 6.9 Hz, 6H,
H24, H26). 13C{1H} NMR (75 MHz, (CD3)2CO): δ 145.5 (C11 or
C14), 144.7 (C11 or C14), 127.7, 124.2, 123.9 (C1, C2, C3, C4), 110.0
(C12, C13), 89.1, 87.3, 87.1, 84.6 (C5, C6, C7, C8), 83.5 (Cp), 80.6 (C9,
C10), 64.9 (C17, C18), 63.0 (C23, C25), 61.2 (C19), 60.8 (C20), 52.5
(C21, C22), 44.5 (C15, C16), 16.9 (C24, C26).
1H NMR (500 MHz, CDCl3): δ 7.48 (m, 2H, Harom), 7.26 (m, 2H,
3
2
Harom), 7.11−7.16 (m, 4H, Harom), 4.16 (dq, JH−H = 6.9 Hz, JH−H
=
8.6 Hz, 2H, H23(a), H25(a)), 4.08 (m, 2H, H17(a), H18(a)), 3.87 (dq, 3JH−H
= 6.9 Hz, 2JH−H = 8.6 Hz, 2H, H23(b), H25(b)), 3.50 (m, 2H, H15, H16),
2.62 (s, 6H, H21, H22), 2.37 (m, 2H, H20), 2.26 (m, 2H, H19), 1.89 (s,
3H, CH3−COO), 1.79 (s, 3H, CH3−COO), 1.67 (m, 2H, H17(b)
,
Synthesis of 6. To a solution of 2 (20 mg, 0.034 mmol) in 5 mL of
degassed dichloromethane was added [RuCp(NCMe)3]PF6 (29.8 mg,
0.068 mmol). The resulting mixture was refluxed overnight. After the
evaporation of the solvent the resulting complex was isolated as a
brown solid (31.8 mg, 0.026 mmol, 77%). Single crystals suitable for
X-ray analysis were obtained from an acetone solution of 6. For NMR
labeling, see Figure S12 in the Supporting Information.
H18(b)), 1.52 (t, JH−H = 6.9 Hz, 6H, H24, H26). 13C{1H} NMR (125
MHz, CDCl3): δ 178.4 (CH3−COO), 178.3 (CH3−COO), 141.9
(C11, C12 or C13, C14), 140.2 (C11, C12 or C13, C14), 126.0 (CHarom),
125.9 (CHarom), 122.4 (CHarom), 120.9 (CHarom), 80.5 (C9, C10), 63.3
(C17, C18), 62.5 (C20), 61.7 (C19), 60.5 (C23, C25), 50.7 (C21, C22),
44.7 (C15, C16), 23.0 (C28), 22.9 (C30), 15.5 (C24, C26). IR (KBr, ν
cm−1): 3447 (C−H), 2973, 2928 (C−H), 1617, 1600 (CO),
1451 (CC), 1073, 1024 (C−O). Anal. Calcd for C30H40N2O6Pd
(631.5): C, 57.01; H, 6.33; N, 4.44. Found: C, 56.86; H, 6.51; N, 4.49.
Synthesis of 4. Ligand 2 (100 mg, 0.246 mmol) was dissolved in
15 mL of toluene, and [PdCl2(COD)] (70.2 mg, 0.246 mmol) was
then added. This mixture was stirred for 15 h at 70 °C. The solvent
was then evaporated, and the obtained solid was washed with diethyl
ether. After it was dried under vacuum, the complex was isolated as a
yellow solid (129.2 mg, 0.222 mmol, 90%). Single crystals suitable for
X-ray analysis were obtained from a dichloromethane/diethyl ether
(1/2) solution of 4. For NMR labeling, see Figure S12 in the
Supporting Information.
3
1H NMR (300 MHz, (CD3)2CO): δ 6.36 (m, 4H, Harom), 6.30 (m,
2H, Harom), 6.27 (m, 2H, Harom), 5.50 (s, 10H, Cp), 4.11 (m, 4H, H23,
H25), 3.67 (m, 2H, H20), 3.10 (m, 2H, H19), 2.78 (m, 6H, H15, H16,
3
H17, H18), 2.70 (s, 6H, H21, H22), 1.52 (t, JH−H = 6.9 Hz, 6H, H24,
H26). 13C{1H} NMR (75 MHz, (CD3)2CO): δ 153.8, 131.7 (C11, C12,
C13, C14), 89.1 (CHarom), 87.3 (CHarom), 86.6 (CHarom), 85.2
(CHarom), 84.2 (Cp), 80.7 (C9, C10), 65.6 (C17, C18), 63.1 (C23,
C25), 61.5 (C19), 60.9 (C20), 52.1 (C21, C22), 44.5 (C15, C16), 16.7
(C24, C26). 31P{1H} NMR (121.4 MHz, (CD3)2CO): δ −144.5 ppm.
IR (KBr, ν cm−1): 3479 (C−H), 2974, 2928 (C−H), 1459 (CC),
1065 (C−O), 842 (P−F). High-resolution mass spectrometry (ES+,
methanol): calcd mass 1005.3069, found mass 1005.3076
(C36H44N2O2ClPdRu2PF5). High-resolution mass spectrometry (ES−,
methanol): calcd mass 144.9642, found mass 144.9642 ([PF6]−).
Synthesis of 8. To a solution of the corresponding aniline ligand17
(20 mg, 0.049 mmol) in 3 mL of degassed dichloroethane was added
[RuCp(NCMe)3]PF6 (21 mg, 0.049 mmol). The resulting mixture
was refluxed overnight. After the evaporation of the solvent the
resulting solid was purified by recrystallization in a dichloromethane/
diethyl ether mixture (1/2). Yield: 20 mg (61%).
1H NMR (300 MHz, CDCl3): δ 7.48−7.51 (m, 2H, Harom), 7.14−
3
2
7.19 (m, 6H, Harom), 4.10−4.18 (dq+m, JH−H = 6.9 Hz, JH−H = 8.6
3
Hz, 4H, H23(a), H25(a) and H17(a), H18(a)), 3.76−3.86 (dq+m, JH−H
6.9 Hz, JH−H = 8.6 Hz, 4H, H23(b), H25(b) and H15, H16), 2.76 (s, 6H,
=
2
H21, H22), 2.42 (m, 2H, H20), 2.14 (br, 2H, H19), 1.95 (m, 2H, H17(b)
,
3
H18(b)), 1.53 (t, JH−H = 6.9 Hz, 6H, H24, H26). 13C{1H} NMR (75
MHz, CDCl3): δ 141.9 (C11, C12 or C13, C14), 140.4 (C11, C12 or C13,
C14), 129.0 (CHarom), 128.2 (CHarom), 126.1 (CHarom), 125.3
(CHarom), 80.9 (C9, C10), 65.1 (C17, C18), 63.7 (C20), 63.4 (C19),
60.7 (C23, C25), 51.8 (C21, C22), 45.8 (C15, C16), 15.5 (C24, C26). IR
(KBr, ν cm−1): 3447 (C−H), 2974, 2928 (C−H), 1459 (CC),
1078, 1025 (C−O). High-resolution mass spectrometry (ES+,
methanol): calcd mass 547.1351 [M − Cl]+, found mass 547.1353
[M − Cl]+ (C26H34ClN2O2Pd). Anal. Calcd for C26H34Cl2N2O2Pd·
CH2Cl2 (667.486): C, 48.54; H, 5.39; N, 4.19. Found: C, 49.78; H,
5.70; N, 3.90.
1H NMR (300 MHz, (CD3)2CO): δ 7.59 (m, 2H, Harom), 7.41 (m,
2H, Harom), 7.19−7.23 (m, 4H, Harom), 5.95 (m, 3H, Harom), 5.72 (m,
2H, Harom), 5.11 (s, 5H, Cp), 4.20 (m, 2H, CH2−CH3), 3.92 (m, 2H,
CH2−CH3), 3.59 (m, 2H, CH2−N), 2.90 (m, 4H, CH and CH2−N),
1.55 (t, 3JH−H = 6.9 Hz, 6H, CH2−CH3). 31P{1H} NMR (121.4 MHz,
(CD3)2CO): δ −143.7 ppm. IR (KBr, ν cm−1): 3113 (C−H), 2973,
2927 (C−H), 1551, 1468 (CC), 1070 (C−O), 836 (P−F).
Procedure for Pd-Catalyzed Suzuki−Miyaura Cross-Cou-
pling. Palladium complex (1 mol %), phenylboronic acid (91.5 mg,
0.75 mmol), and Na2CO3 (106 mg, 1.0 mmol) dissolved in 0.5 mL of
deoxygenated water were dissolved in 2 mL of dried toluene. 4-
Bromoanisole (93.5 mg, 0.5 mmol) was then added. The mixture was
heated to 65 °C for the corresponding time. A 15 mL portion of
diethyl ether was added, and the organic phase was consecutively
washed with a NaOH aqueous solution (1 M) and water. The organic
phase was dried on Na2SO4, filtered, concentrated under vacuum, and
Synthesis of 5. To a solution of 2 (25 mg, 0.043 mmol) in 5 mL of
degassed dichloromethane was added [RuCp(NCMe)3]PF6 (18.6 mg,
0.043 mmol). The resulting mixture was refluxed overnight. After
evaporation of the solvent the resulting complex was isolated as an
orange solid (29.9 mg, 0.033 mmol, 78%). Single crystals suitable for
X-ray analysis were obtained from an acetone solution of 5. For NMR
labeling, see Figure S12 in the Supporting Information.
31P{1H} NMR (121.4 MHz, (CD3)2CO): δ −144.5 ppm. IR (KBr,
ν cm−1): 3481 (C−H), 2976, 2930 (C−H), 1458 (CC), 1068
(C−O), 841 (P−F). High-resolution mass spectrometry (ES+,
methanol): calcd mass 750.0480, found mass 750.0475
(C31H39Cl2N2O2PdRu). High-resolution mass spectrometry (ES−,
methanol): calcd mass 144.9642, found mass 144.9644 ([PF6]−).
Anal. Calcd for C31H39Cl2F6N2O2PPdRu·CH2Cl2 (979.923): C, 39.19;
H, 4.18; N, 2.86. Found: C, 39.83; H, 4.59; N, 2.40.
1
analyzed by gas chromatography and H NMR.
Electrochemical Measurements. Experiments were performed
at room temperature in a homemade airtight three-electrode cell
connected to a vacuum/argon line. The reference electrode consisted
of a saturated calomel electrode (SCE) separated from the solution by
a bridge compartment. The counter electrode was a platinum wire of
ca. 1 cm2 apparent surface or a glassy-carbon disk 1 mm in diameter.
The solutions used during the electrochemical studies were typically
10−3 mol L−1 in complex compound and 0.1 mol L−1 in supporting
electrolyte. The supporting electrolyte (nBu4N)[PF6] (Fluka, 99%
electrochemical grade) was used as received and simply degassed
under argon. Acetonitrile was used from the MBraun SPS-800 solvent
purification system. Before each measurement, the solutions were
degassed by bubbling Ar and the working electrode was polished with
a polishing machine (Presi P230). Potentials are given vs the Fc+/Fc
couple as internal standard (E1/2 = 0.4 V/SCE).
Data for maj-5 (70%) are as follows. 1H NMR (300 MHz,
(CD3)2CO): δ 7.48 (m, 2H, Harom), 7.23 (m, 2H, Harom), 7.17 (m, 2H,
Harom), 6.32 (m, 2H, Harom), 5.49 (s, 5H, Cp), 4.13 (m, 4H, H23, H25),
3.65 (m, 2H, H20), 3.55 (m, 2H, H15, H16), 2.96 (m, 4H, H17, H18),
3
2.83 (m, 2H, H19), 2.70 (s, 6H, H21, H22), 1.48−1.56 (t, JH−H = 6.9
Hz, 6H, H24, H26). 13C{1H} NMR (75 MHz, (CD3)2CO): δ 142.0
(C11 or C14), 139.0 (C11 or C14), 129.7, 127.9, 127.5, 122.7 (C1, C2,
C3, C4), 113.6 (C12, C13), 87.3 (CHarom), 83.2 (Cp), 83.0, 82.9, 82.0
(CHarom), 80.5 (C9, C10), 66.3 (C17, C18), 61.9 (C23, C25), 61.4 (C19),
60.8 (C20), 52.0 (C21, C22), 44.8 (C15, C16), 16.8 (C24, C26).
X-ray Diffraction Data Collection and Structure Solution
Refinement. The X-ray data (see the Supporting Information, Table
S2) for single crystals of ligand 2 and complexes 3−6 were obtained at
Data for min-5 (30%) are as follows. 1H NMR (300 MHz,
(CD3)2CO): δ 7.57 (m, 2H, Harom), 7.35 (m, 2H, Harom), 6.52 (m, 2H,
1817
dx.doi.org/10.1021/om5001502 | Organometallics 2014, 33, 1812−1819